Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Recruiting3
Not Yet Recruiting3
Unknown1

Clinical Trials (7)

Showing 7 of 7 trials
NCT07806877Not ApplicableNot Yet Recruiting

Efficacy and Safety of Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in Schizophrenia

NCT07147309Recruiting

Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

NCT07552207Not ApplicableNot Yet Recruiting

Comparison of [68Ga]Ga-CTR-FAPI and 18F-FDG PET/MRI for Lymph Node Staging in Rectal Cancer

NCT07558577Not ApplicableNot Yet Recruiting

Research on the Application of Sigma Radiopharmaceutical FBFP in Cerebral Stroke

NCT07004673Recruiting

18F FDG and 68Ga FAPI PET/MR Imaging of Carotid Artery Plaque Vulnerability: A Clinical Study in Carotid Artery Plaque Patients

NCT07130409Recruiting

Multimodal Imaging Assessment After Revascularization in Patients With Acute Myocardial Infarction

NCT04045834Unknown

Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia

Showing all 7 trials

Research Network

Activity Timeline